Calidi Biotherapeutics signs lease agreement for office space.
Calidi Biotherapeutics entered a 44-month lease for 9,038 square feet. This agreement outlines rent obligations and terms through 2030.
View filing at SEC.gov →3 most recent filings and news items mentioning CLDI. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/CLDI/news?limit=20"
Pull CLDI filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayCalidi Biotherapeutics entered a 44-month lease for 9,038 square feet. This agreement outlines rent obligations and terms through 2030.
View filing at SEC.gov →Calidi Biotherapeutics has appointed former Genentech and Celgene executive Dr. Corsee Sanders to its board of directors. This addition brings decades of clinical development experience to the team as Calidi advances its proprietary genetic medicine pipeline.
View filing at SEC.gov →Calidi Biotherapeutics issued an amended and restated warrant agreement for common stock purchases with modified exercise terms and conditions. The filing reflects standard warrant restructuring typical of biotech equity financing activities.
View filing at SEC.gov →